Avantor® to Participate in 44th Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Avantor (NYSE: AVTR) announced that Emmanuel Ligner, President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at approximately 8:15 a.m. Pacific Standard Time. A live audio webcast will be available through the company’s Investor Events & Presentations page at ir.avantorsciences.com, and a replay will be accessible for 30 days.
Positive
- None.
Negative
- None.
News Market Reaction – AVTR
In the Jan 5 session, AVTR gained 3.75%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Dec 18 | Board appointment | Positive | -0.3% | New director added to support Avantor Revival plan and governance depth. |
| Dec 04 | Board appointment | Positive | -2.0% | Experienced private equity leader joins board to aid Revival plan execution. |
| Nov 25 | Innovation award | Positive | +3.0% | Edison Patent Award for sustainable viral inactivation technology with process benefits. |
| Nov 19 | Facility expansion | Positive | -1.2% | New Boston-area centralized service center to support lab efficiency and logistics. |
| Nov 10 | Executive appointment | Positive | -0.4% | New COO to lead manufacturing and supply chain aligned with growth strategy. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent positive corporate and strategic updates often saw flat-to-negative next-day moves, with only one clearly positive reaction.
Over the last few months, Avantor reported several corporate developments, including leadership changes and operational initiatives. Board appointments on Dec 4, 2025 and Dec 18, 2025 tied to the Avantor Revival plan drew modestly negative price reactions. By contrast, a Nov 25, 2025 technology recognition for sustainable viral inactivation correlated with a +2.95% move. Operational expansion via a Boston-area service center and appointment of a new COO in November saw small negative reactions, indicating mixed market reception to otherwise constructive news.
AI-generated analysis. How Rhea-AI works. Not financial advice.
To hear a live audio webcast of the session, visit Events & Presentations in the Investor section of Avantor's website, ir.avantorsciences.com. A replay of the webcast will be available for 30 days.
About Avantor
Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedIn, X (Twitter) and Facebook.
Investor Relations Contact
Allison Hosak
Senior Vice President, Global Communications
Avantor
908-329-7281
Allison.Hosak@avantorsciences.com
Global Media Contact
Eric Van Zanten
Head of External Communications
Avantor
610-529-6219
Eric.VanZanten@avantorsciences.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/avantor-to-participate-in-44th-annual-jp-morgan-healthcare-conference-302647214.html
SOURCE Avantor and Financial News